换一批
第一作者：
Lavinia,Spain
第一单位：
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.;Department of Medical Oncology, Peter MacCallum Cancer -Centre, Melbourne, Australia.
作者：
Lavinia,Spain [1]
;
Alexander,Coulton [2]
;
Irene,Lobon [3]
;
Andrew,Rowan [4]
;
Desiree,Schnidrig [3]
;
Scott T C,Shepherd [5]
;
Benjamin,Shum [5]
;
Fiona,Byrne [3]
;
Maria,Goicoechea [3]
;
Elisa,Piperni [3]
;
Lewis,Au [6]
;
Kim,Edmonds [7]
;
Eleanor,Carlyle [7]
;
Nikki,Hunter [7]
;
Alexandra,Renn [7]
;
Christina,Messiou [8]
;
Peta,Hughes [9]
;
Jaime,Nobbs [9]
;
Floris,Foijer [10]
;
Hilda,van den Bos [10]
;
Rene,Wardenaar [10]
;
Diana C J,Spierings [10]
;
Charlotte,Spencer [5]
;
Andreas M,Schmitt [7]
;
Zayd,Tippu [5]
;
Karla,Lingard [7]
;
Lauren,Grostate [7]
;
Kema,Peat [7]
;
Kayleigh,Kelly [7]
;
Sarah,Sarker [7]
;
Sarah,Vaughan [7]
;
Mary,Mangwende [7]
;
Lauren,Terry [7]
;
Denise,Kelly [7]
;
Jennifer,Biano [7]
;
Aida,Murra [7]
;
Justine,Korteweg [7]
;
Charlotte,Lewis [7]
;
Molly,O'Flaherty [7]
;
Anne-Laure,Cattin [3]
;
Max,Emmerich [11]
;
Camille L,Gerard [12]
;
Husayn Ahmed,Pallikonda [3]
;
Joanna,Lynch [7]
;
Robert,Mason [13]
;
Aljosja,Rogiers [14]
;
Hang,Xu [15]
;
Ariana,Huebner [16]
;
Nicholas,McGranahan [17]
;
Maise,Al Bakir [18]
;
Jun,Murai [19]
;
Cristina,Naceur-Lombardelli [20]
;
Elaine,Borg [21]
;
Miriam,Mitchison [21]
;
David A,Moore [22]
;
Mary,Falzon [21]
;
Ian,Proctor [21]
;
Gordon W H,Stamp [15]
;
Emma L,Nye [15]
;
Kate,Young [9]
;
Andrew J S,Furness [23]
;
Lisa,Pickering [7]
;
Ruby,Stewart [22]
;
Ula,Mahadeva [22]
;
Anna,Green [22]
;
James,Larkin [22]
;
Kevin,Litchfield [24]
;
Charles,Swanton [4]
;
Mariam,Jamal-Hanjani [25]
;
PEACE Consortium [5]
;
Samra,Turajlic
作者单位：
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.;Department of Medical Oncology, Peter MacCallum Cancer -Centre, Melbourne, Australia.
[1]
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom.
[2]
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.
[3]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
[4]
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
[5]
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.;Department of Medical Oncology, Peter MacCallum Cancer -Centre, Melbourne, Australia.;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
[6]
The Royal Marsden Hospital, London, United Kingdom.
[7]
The Royal Marsden Hospital, London, United Kingdom.;The Institute of Cancer Research, Kensington and Chelsea, United Kingdom.
[8]
Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
[9]
European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
[10]
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;St. John's Institute of Dermatology, Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom.
[11]
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;Precision Oncology Center, Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
[12]
Gold Coast University Hospital, Queensland, Australia.
[13]
Cancer Dynamics Laboratory, The Francis Crick Institute, London, United Kingdom.;The Royal Marsden Hospital, London, United Kingdom.
[14]
The Francis Crick Institute, London, United Kingdom.
[15]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.;Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.;Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.
[16]
Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.
[17]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.;Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.
[18]
Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom.;Drug Discovery Technology Laboratories, Ono Pharmaceutical Co., Ltd. Osaka, Japan.
[19]
Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.
[20]
University College London Hospital, London, United Kingdom.
[21]
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
[22]
Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.;The Institute of Cancer Research, Kensington and Chelsea, United Kingdom.
[23]
Tumour Immunogenomics and Immunosurveillance (TIGI) Lab, UCL Cancer Institute, London, United Kingdom.
[24]
Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, United Kingdom.;Cancer Metastasis Laboratory, University College London Cancer Institute, London, United Kingdom.;Department of Medical Oncology, University College London Hospitals, London, United Kingdom.
[25]
医学主题词
人类(Humans);黑色素瘤(Melanoma);突变(Mutation);进化, 分子(Evolution, Molecular);脑肿瘤(Brain Neoplasms);DNA(DNA)
DOI
10.1158/2159-8290.CD-22-1427
PMID
36977461
发布时间
2025-05-30
- 浏览1
Cancer discovery
Cancer discovery
1364-1385页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
